))
Viracta and Burgeon Brewing Company
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on April 04, 2023 20:36 (
What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 324973178 series 2971598
Innhold levert av Daniel Schroeder. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Daniel Schroeder eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
In this episode of The Biotech and Breweries Podcast, Noah Scoville, Manager at Burgeon Brewing, shares four beers from the craft beer brewery: Invita Mexican Lager, Carlsbad Crush, Treevana IPA, and Juice Press.
Dan Chevallard, COO and Chief Financial Officer of Viracta shares his journey with Viracta and their pursuit of EBV-associated cancers with a combination drug product. He discusses the evolution of Viracta as a company, their targeted approach to merging oncology with virology, and how to fundraise with a bridge mentality and not a pyramid mentality.
Quotes:
“Community is such a core thing for us and making great beer is a huge thing as well. Without good beer, especially in San Diego with 160 different breweries, you’re kind of gonna get drowned out. There is a lot of noise. So you’ve got to have great beer to separate yourself from the others.” - Noah Scoville [03:38]
“For an individual who is trying to start a company: have a mentor. You have to have someone you can talk to that’s seen it, done and that you can bounce ideas off of. Operating in a silo is not ideal.” - Dan Chevallard [34:01]
Topics discussed:
- Burgeon Beer
- Brews: Invita Mexican Lager, Carlsbad Crush, Treevana IPA, and Juice Press
- Dan’s journey in BioScience
- Viracta’s progress
- The intersection of Oncology and Virology
- Accessing the public market
- Dan’s fundraising advice
Resources:
Connect with Viracta:
Connect with Burgeon Brewing:
SUBSCRIBE: Subscribe to the podcast to make sure you never miss an episode.
18 episoder
Del
